HealthInvest Partners’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

HealthInvest Partners’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,140,222	Closed	-$5.47M	–	15
2017 Q1	$5.47M	Buy	+1,140,222	New	+$6.19M	8.39%	7

Other funds holding OSIR

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

HealthInvest Partners's OSIR Position: Q2 2017 in Review

HealthInvest Partners sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2017, closing a stake of 1,140,222 shares — an estimated $5.47M sold.

HealthInvest Partners first reported a position in OSIR in Q1 2017 and held it in 1 quarter. The position peaked at $5.47M in Q1 2017. 3 funds tracked by Wall St. Rank hold OSIR as of Q2 2017.

HealthInvest Partners reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
HealthInvest Partners sold 1,140,222 Osiris Therapeutics, Inc. Common Stock shares in Q2 2017, an estimated $5.47M.
HealthInvest Partners first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
HealthInvest Partners's Osiris Therapeutics, Inc. Common Stock position peaked at $5.47M in Q1 2017.
3 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2017.

Based on HealthInvest Partners's 13F filing for Q2 2017, filed 7 Aug 2017.